Delivery Order SPE2DB22D2206-SPE2DB25FJN92
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TAVNEOS 10 mg capsules (180-count units) on September 17, 2025, with a ceiling value of $10,218.17 and completion deadline of October 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 28, 2025, by the Defense Logistics Agency to supply 60 tablets of Tibsovo 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $43,654.80 and is scheduled for completion by October 20, 2025. The contract contains no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Talvey 40 mg/ml vials valued at $13,518.20, with completion scheduled for December 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a $13,083.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TIVDAK 40 mg vials, with an ultimate completion date of June 24, 2025. This non-set-aside delivery order represents a single pharmaceutical procurement under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 10, 2025, for Tavalisse 150 mg tablets (60-count packaging) with a ceiling value of $37,127.34. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by October 1, 2025. The award represents a continuation of the contractor's substantial role in supporting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 7, 2025, by the Defense Logistics Agency (DLA) for TAFINLAR 75 mg capsules (120-count units) with a ceiling value of $17,730.91. The contract is structured as a firm fixed-price delivery order with a completion date of December 2, 2025. This award was not designated as a set-aside and was competitively awarded, consistent with AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $14,221.60 on June 30, 2025, for the supply of Enhertu 100 mg vials with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a pediatric-focused pharmaceutical procurement supporting federal medical supply requirements. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp received a delivery order valued at $21,806.25 from the Defense Logistics Agency for 40 mg vials of TIVDAK, awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trodelvy 180 mg vials valued at $9,584.58. This is a firm fixed-price delivery order with no set-aside designation, to be completed by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trodelvy 180 mg vials, with a contract ceiling value of $31,948.60 and an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...